The Leeper laboratory studies the vascular biology of atherosclerosis and aneurysm disease.

Dr. DiRenzo's overarching research goal is to use techniques from the basic sciences and human clinical sciences to improve the prevention and management of voice disorders.

Dr. Jacobs's clinical interests include general oncology, and sarcomas.

The Fordyce Lab is focused on developing new instrumentation and assays for making quantitative, systems-scale biophysical measurements of molecular interactions.

The Stanford Neurosurgical Outcomes Laboratory aims to analyze and solve healthcare problems relating to neurosurgical and spine care on a population level.

Dr. Peay's lab studies the ecological processes that structure natural communities and the links between community structure and the cycling of nutrients and energy through ecosystems.

Dr. Buckingham's major interest is in type 1 diabetes mellitus, continuous glucose sensor, and the development of an artificial pancreas.

The long-term goal of Dr. Chen's research is to understand the cellular and molecular mechanisms that underlie synapse function during behavior in the developing and mature brain, and how synapse function is altered during mental retardation.

Dr. Horowitz's current research interests are quite broad and span using EE and CS analysis methods to problems in molecular biology to creating new design methodologies for analog and digital VLSI circuits.

Dr. McLaughlin conducts a number of clinical research studies related to obesity, insulin resistance, diabetes, and cardiovascular disease.